China Suntien (00956): Su Shuai appointed as the continuing supervisory sponsor representative.
New Heaven Green Energy (00956) released an announcement, New Heaven Green Energy Co., Ltd. (hereinafter referred to as the "Company") officially...
CHINA SUNTIEN (00956) issued an announcement stating that the company recently received a notice from the sponsor institution ZhongDe Securities Co., Ltd. (hereinafter referred to as "ZhongDe Securities") regarding the replacement of the continuous supervision representative for CHINA SUNTIEN Co., Ltd. ZhongDe Securities, as the sponsor institution for the company's issuance of A shares to specific targets in 2021, originally designated Mr. Sun Naiwei and Mr. Lan Jianzhou to serve as the continuous supervision representatives for the company. Due to work changes for Mr. Lan Jianzhou, he can no longer continue to serve as the continuous supervision representative for the company. In order to ensure the smooth progress of the company's continuous supervision work, ZhongDe Securities has appointed Mr. Su Shuai to replace Mr. Lan Jianzhou as the continuous supervision representative for the company starting from November 12, 2025, continuing to fulfill the responsibilities of continuous supervision for the company.
After this change, the continuous supervision representatives for the company are Mr. Sun Naiwei and Mr. Su Shuai, and the period of continuous supervision will continue until the end of the continuous supervision obligation as specified by the China Securities Regulatory Commission and the Shanghai Stock Exchange.
Related Articles

LIVZON PHARMA (01513): Independent director candidate Wang Zhiyao obtains Shenzhen Stock Exchange Independent Director Training Certification.

The end of the era of the COVID-19 pandemic: Pfizer Inc. (PFE.US) plans to sell off its shares in BioNTech (BNTX.US), marking the conclusion of their iconic vaccine partnership.

BEKE-W(02423) cancelled 37.8061 million repurchased shares on November 13th.
LIVZON PHARMA (01513): Independent director candidate Wang Zhiyao obtains Shenzhen Stock Exchange Independent Director Training Certification.

The end of the era of the COVID-19 pandemic: Pfizer Inc. (PFE.US) plans to sell off its shares in BioNTech (BNTX.US), marking the conclusion of their iconic vaccine partnership.

BEKE-W(02423) cancelled 37.8061 million repurchased shares on November 13th.

RECOMMEND

Younger consumers are dining out less at Chipotle and Cava while still buying Coach handbags
10/11/2025

Target’s deteriorating in-store experience risks recovery — retailer bets on a refined fulfillment model to fix it
10/11/2025

China suspends approval ban on exports of certain metals used in chip and electronics manufacturing to the U.S.
10/11/2025


